Editas Medicine, Inc.
EDIT
$1.28
$0.010.79%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 26.95% | 8.08% | -9.13% | -228.23% | 58.08% |
| Total Depreciation and Amortization | -13.63% | 12.61% | 0.78% | -3.89% | -3.17% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 48.02% | 33.15% | -53.74% | 80.31% | -6.57% |
| Change in Net Operating Assets | -378.84% | -32.31% | 33.54% | 159.35% | -277.27% |
| Cash from Operations | 3.47% | 7.84% | -14.42% | -124.24% | 37.28% |
| Capital Expenditure | 81.51% | 16.40% | -86.75% | -43.15% | -446.86% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -63.75% | 56.72% | 2,029.30% | -104.48% | 162.53% |
| Cash from Investing | -63.14% | 61.64% | 1,194.92% | -107.55% | 161.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 67.71% | -62.65% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | 67.71% | -62.65% | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 13.76% | 755.89% | 91.21% | -232.38% | 129.73% |